1. Home
  2. List
Reference Patent

Reference - List

  • 12 Hits
  • Search Condition : Filter (MeSH = Pyridones / pharmacology)
Species Resource Title
Human and Animal Cells WI-38 Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for idiopathic pulmonary fibrosis.
Human and Animal Cells HCE-T(RCB2280) Controllable release of pirfenidone by polyvinyl alcohol film embedded soft contact lenses in vitro and in vivo.
Human and Animal Cells PC-9(RCB4455) Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer.
Human and Animal Cells Lu-130(RCB0465) PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer.
Human and Animal Cells A549 Analysis of TGF-β1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE/Abca3.
Human and Animal Cells KP4(RCB1005) SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy.
Human and Animal Cells HSC-2(RCB1945) ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma.
DNA material CSII-CMV-RfA (RDB04386) SAA1 is upregulated in gastric cancer-associated fibroblasts possibly by its enhancer activation.
Human and Animal Cells CACO-2(RCB0988) Low‑dose trametinib and Bcl‑xL antagonist have a specific antitumor effect in KRAS‑mutated colorectal cancer cells.
Human and Animal Cells 293(RCB1637) Inhibitory effects of AG490 on H2O2-induced TRPM2-mediated Ca(2+) entry.
Human and Animal Cells RAW 264(RCB0535) Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis.
Human and Animal Cells TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) , TGBC14TKB8RCB1186) , TFK-1(RCB2537) , HuH-28(RCB1943) , TKKK(RCB1907) Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.